Jefferies Financial Group Forecasts Strong Price Appreciation for COPT Defense Properties (NYSE:CDP) Stock

COPT Defense Properties (NYSE:CDP) had its price target lifted by stock analysts at Jefferies Financial Group from $33.00 to $34.00 in a report released on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group’s target price suggests a potential upside of 14.96% from the company’s current price.

CDP has been the subject of several other research reports. Truist Financial upped their price objective on shares of COPT Defense Properties from $30.00 to $31.00 and gave the company a “hold” rating in a research note on Monday, December 15th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of COPT Defense Properties in a research report on Wednesday, January 21st. Evercore ISI decreased their price objective on COPT Defense Properties from $35.00 to $34.00 and set an “outperform” rating for the company in a report on Monday, December 15th. Wells Fargo & Company lifted their target price on shares of COPT Defense Properties from $30.00 to $33.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Finally, New Street Research set a $33.00 price target on shares of COPT Defense Properties in a research note on Monday, October 13th. Five investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $33.00.

COPT Defense Properties Stock Performance

Shares of COPT Defense Properties stock opened at $29.58 on Tuesday. The firm has a market capitalization of $3.35 billion, a P/E ratio of 22.24 and a beta of 0.86. COPT Defense Properties has a 52 week low of $23.92 and a 52 week high of $31.24. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 1.57. The firm’s 50 day moving average is $29.42 and its two-hundred day moving average is $28.94.

COPT Defense Properties (NYSE:CDP) last issued its quarterly earnings data on Thursday, October 30th. The company reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.68 by $0.01. The business had revenue of $188.80 million during the quarter, compared to the consensus estimate of $187.63 million. COPT Defense Properties had a net margin of 19.99% and a return on equity of 9.71%. The company’s revenue was down .2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.65 EPS. Research analysts forecast that COPT Defense Properties will post 2.67 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Financial Consulate Inc. purchased a new stake in shares of COPT Defense Properties during the 3rd quarter worth $39,000. GAMMA Investing LLC boosted its holdings in COPT Defense Properties by 59.5% during the second quarter. GAMMA Investing LLC now owns 1,504 shares of the company’s stock worth $41,000 after buying an additional 561 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in COPT Defense Properties by 1,176.5% during the second quarter. EverSource Wealth Advisors LLC now owns 1,685 shares of the company’s stock worth $46,000 after buying an additional 1,553 shares during the period. Optima Capital LLC purchased a new position in COPT Defense Properties in the fourth quarter valued at about $63,000. Finally, Osaic Holdings Inc. lifted its position in shares of COPT Defense Properties by 59.6% during the 2nd quarter. Osaic Holdings Inc. now owns 3,193 shares of the company’s stock valued at $88,000 after acquiring an additional 1,192 shares during the period.

About COPT Defense Properties

COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.

The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.